Risks of Impaired Organ Protection with Inhibiting Transient Receptor Potential Vanilloid 1
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Otto M, Bucher C, Liu W, Muller M, Schmidt T, Kardell M J Clin Invest. 2020; 130(9):4999-5010.
PMID: 32584793 PMC: 7456227. DOI: 10.1172/JCI136621.
References
1.
Wang L, Wang D
. TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation. 2005; 112(23):3617-23.
DOI: 10.1161/CIRCULATIONAHA.105.556274.
View
2.
Wang Y, Babankova D, Huang J, Swain G, Wang D
. Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension. Hypertension. 2008; 52(2):264-70.
PMC: 2669743.
DOI: 10.1161/HYPERTENSIONAHA.108.110197.
View
3.
Wang M, Ji P, Wang R, Zhao L, Xia Z
. TRPV1 agonist capsaicin attenuates lung ischemia-reperfusion injury in rabbits. J Surg Res. 2010; 173(1):153-60.
DOI: 10.1016/j.jss.2010.08.053.
View
4.
Muzzi M, Felici R, Cavone L, Gerace E, Minassi A, Appendino G
. Ischemic neuroprotection by TRPV1 receptor-induced hypothermia. J Cereb Blood Flow Metab. 2012; 32(6):978-82.
PMC: 3367226.
DOI: 10.1038/jcbfm.2012.36.
View
5.
Chen L, Marko L, Kassmann M, Zhu Y, Wu K, Gollasch M
. Role of TRPV1 channels in ischemia/reperfusion-induced acute kidney injury. PLoS One. 2014; 9(10):e109842.
PMC: 4201466.
DOI: 10.1371/journal.pone.0109842.
View